Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma. A phase II International Oncology Study Group study.
about
Liposomal daunorubicin and dexamethasone as a treatment for multiple myeloma--the DD Protocol.Drug conjugates such as Antibody Drug Conjugates (ADCs), immunotoxins and immunoliposomes challenge daily clinical practice.Diagnosis and Treatment of Kaposi Sarcoma.A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma.
P2860
Liposomal daunorubicin (DaunoXome) plus dexamethasone for patients with multiple myeloma. A phase II International Oncology Study Group study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Liposomal daunorubicin (DaunoX ...... al Oncology Study Group study.
@ast
Liposomal daunorubicin (DaunoX ...... al Oncology Study Group study.
@en
type
label
Liposomal daunorubicin (DaunoX ...... al Oncology Study Group study.
@ast
Liposomal daunorubicin (DaunoX ...... al Oncology Study Group study.
@en
prefLabel
Liposomal daunorubicin (DaunoX ...... al Oncology Study Group study.
@ast
Liposomal daunorubicin (DaunoX ...... al Oncology Study Group study.
@en
P2093
P2860
P356
P1433
P1476
Liposomal daunorubicin (DaunoX ...... al Oncology Study Group study.
@en
P2093
Ann F Mohrbacher
Don A Gabriel
Francis J Giles
Jason M Rusk
Stephanie A Gregory
P2860
P304
P356
10.1002/CNCR.10561
P407
P577
2002-05-01T00:00:00Z